Patents by Inventor Michael Organ
Michael Organ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11680955Abstract: A fluid diverting module includes a multi-position fluid diverting device comprising three-dimensional movable flow-paths with minimal tortuosity in the movable portion (the rotor) of the fluid diverting device. In some embodiments, the device is also equipped with a filtration module that is capable of filtering solid particulates from fluidic samples. The invention relates to an area of non-disruptive sampling from various sample sources including ones containing solids. The fluid diverting device maintains fluid communication between the sample source and a pressure creating device in all positions of the fluid diverting device, thus conserving the pressure inside the sample source during sampling. The sampling operation is controlled from a controller, which is equipped with a software for manual or intelligent control.Type: GrantFiled: April 4, 2019Date of Patent: June 20, 2023Assignee: Total Synthesis Ltd.Inventors: Michael Organ, Debasis Mallik, Wenyao Zhang
-
Publication number: 20210404998Abstract: A multidimensional chromatographic assembly includes a chromatographic medium selector module, which receives a sample from an injector module and moves the sample through one of at least two chromatographic media of a chromatographic medium module using at least one eluent from at least one fluid moving module. At least a portion of the sample is re-circulated through the same or the second chromatographic medium using a multi-configuration fluid diverting module, which isolates a selected portion of the chromatographed eluent containing at least a portion of the sample in at least one fluid holding compartment and later moves the isolated portion through one of the chromatographic media in an iterative manner until all attributes of the isolated portion in question are analyzed.Type: ApplicationFiled: June 23, 2021Publication date: December 30, 2021Inventors: Michael Organ, Debasis Mallik, Jee Seong Kwak, Wenyao Zhang
-
Patent number: 10585071Abstract: A multidimensional chromatographic assembly includes a pump module, an injector, a path selector device, an array of chromatographic media, a loop selector device and a detector assembly for receiving at least a portion of an analyte stream and flowing the injected stream into the detector assembly via a chromatographic medium (the first dimension). At least a portion of the analyte of interest is then channeled into a chromatographic medium of interest (the second dimension) and re-circulated through the detector assembly. The iteration (multidimension) is continued until all aspects of the chromatogram and the peaks are judged to be analyzed. The entire process is controlled from a computer and the results are collected to make decisions on the analytical and the process controls.Type: GrantFiled: November 10, 2016Date of Patent: March 10, 2020Inventors: Michael Organ, Debasis Mallik
-
Patent number: 10583432Abstract: A sampling module of a fluid processing apparatus includes at least one multi-configuration device connected to a filtration module. The invention relates to an area of non-disruptive sampling from any flow stream including the ones containing solids. The fluid processing apparatus remains in fluid communication with a sample processing module in all configurations of the sampling module and the parameters deemed critical for a chemical process remain unaffected during the sampling event. The entire event is controlled from a computer and the results are collected to make decisions on analytical and process controls.Type: GrantFiled: February 24, 2017Date of Patent: March 10, 2020Inventors: Michael Organ, Debasis Mallik, Jee Seong Kwak
-
Publication number: 20190310278Abstract: A fluid diverting module includes a multi-position fluid diverting device comprising three-dimensional movable flow-paths with minimal tortuosity in the movable portion (the rotor) of the fluid diverting device. In some embodiments, the device is also equipped with a filtration module that is capable of filtering solid particulates from fluidic samples. The invention relates to an area of non-disruptive sampling from various sample sources including ones containing solids. The fluid diverting device maintains fluid communication between the sample source and a pressure creating device in all positions of the fluid diverting device, thus conserving the pressure inside the sample source during sampling. The sampling operation is controlled from a controller, which is equipped with a software for manual or intelligent control.Type: ApplicationFiled: April 4, 2019Publication date: October 10, 2019Inventors: Michael Organ, Debasis Mallik, Wenyao Zhang
-
Publication number: 20180128795Abstract: A multidimensional chromatographic assembly includes a pump module, an injector, a path selector device, an array of chromatographic media, a loop selector device and a detector assembly for receiving at least a portion of an analyte stream and flowing the injected stream into the detector assembly via a chromatographic medium (the first dimension). At least a portion of the analyte of interest is then channeled into a chromatographic medium of interest (the second dimension) and re-circulated through the detector assembly. The iteration (multidimension) is continued until all aspects of the chromatogram and the peaks are judged to be analyzed. The entire process is controlled from a computer and the results are collected to make decisions on the analytical and the process controls.Type: ApplicationFiled: November 10, 2016Publication date: May 10, 2018Inventors: Michael Organ, Debasis Mallik
-
Publication number: 20170248502Abstract: A sampling module of a fluid processing apparatus includes at least one multi-configuration device connected to a filtration module. The invention relates to an area of non-disruptive sampling from any flow stream including the ones containing solids. The fluid processing apparatus remains in fluid communication with a sample processing module in all configurations of the sampling module and the parameters deemed critical for a chemical process remain unaffected during the sampling event. The entire event is controlled from a computer and the results are collected to make decisions on analytical and process controls.Type: ApplicationFiled: February 24, 2017Publication date: August 31, 2017Inventors: Michael Organ, Debasis Mallik, Jee Seong Kwak
-
Patent number: 9579625Abstract: A fluid processing assembly includes a lumen for receiving at least one inlet stream and dispensing a primary product stream, and an energizing device for supplying energy to an energizable portion of the lumen. A primary product collection assembly is in fluid communication with the lumen for receiving the primary product stream. The energizable portion is positioned exterior to the primary product collection assembly. A pressurized gas source is downstream of the lumen. The pressurized gas source supplies pressurized gas to the primary product collection assembly for pressurizing at least a portion of the primary product collection assembly and the lumen.Type: GrantFiled: September 20, 2013Date of Patent: February 28, 2017Assignee: Total Synthesis Ltd.Inventors: Michael Organ, Debasis Mallik
-
Publication number: 20140087036Abstract: A fluid processing assembly comprises a lumen for receiving at least one inlet stream and dispensing a primary product stream, and an energizing device for supplying energy to an energizable portion of the lumen. A primary product collection assembly is in fluid communication with the lumen for receiving the primary product stream. The energizable portion is positioned exterior to the primary product collection assembly. A pressurized gas source is downstream of the lumen. The pressurized gas source supplies pressurized gas to the primary product collection assembly for pressurizing at least a portion of the primary product collection assembly and the lumen.Type: ApplicationFiled: September 20, 2013Publication date: March 27, 2014Applicant: TOTAL SYNTHESIS LTD.Inventors: Michael ORGAN, Debasis MALLIK
-
Patent number: 8158810Abstract: Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.Type: GrantFiled: February 13, 2009Date of Patent: April 17, 2012Assignees: Gilead Sciences, Inc., The Endowment For Research in Human Biology, Inc.Inventors: Jeff Zablocki, Matthew Abelman, Michael Organ, Yaroslav Bilokin, Elfatih Elzein, Tetsuya Kobayashi, Rao Kalla, Thao Perry, Xiaofen Li, Robert Jiang, Ivan Diamond, Lina Yao, Peidong Fan, Maria Pia Arolfo, Zhan Jiang, Wing Ming Keung, Guoxin Tao
-
Patent number: 7951813Abstract: Disclosed are novel quinazolinone derivatives of formula: wherein: R1 is optionally substituted phenyl or optionally substituted heteroaryl; R2 is 3-hydroxy, 4-hydroxy, 3-NHR4 or 4-NHR4, in which R4 is hydrogen, —C(O)R5, —C(O)NHR6, or —SO2R6; in which R5 is optionally substituted lower alkyl or optionally substituted lower alkoxy; and R6 is optionally substituted lower alkyl; R3 is hydrogen, lower alkyl, lower alkoxy, or halo; V is oxygen, sulfur, or —NH—; and W is lower alkylene of 1-3 carbon atoms, which are useful as ALDH-2 inhibitors for treating mammals for various disease states, such as treatment for cocaine dependency and alcohol dependency.Type: GrantFiled: April 3, 2008Date of Patent: May 31, 2011Assignee: Gilead Sciences, Inc.Inventors: Matthew Abelman, Michael Organ, Jeff Zablocki, Wing Ming Keung, Guoxin Tao
-
Publication number: 20090209533Abstract: Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.Type: ApplicationFiled: February 13, 2009Publication date: August 20, 2009Inventors: Jeff Zablocki, Matthew Abelman, Michael Organ, Yaroslav Bilokin, Elfatih Elzein, Tetsuya Kobayashi, Rao Kalla, Thao Perry, Xiaofen Li, Robert Jiang, Ivan Diamond, Lina Yao, Peidong Fan, Maria Pia Arolfo, Zhan Jiang, Wing Ming Keung, Guoxin Tao
-
Publication number: 20080249116Abstract: Disclosed are novel quinazolinone derivatives, useful as ALDH-2 inhibitors for treating mammals for various disease states, such as treatment for cocaine dependency or alcohol dependency.Type: ApplicationFiled: April 3, 2008Publication date: October 9, 2008Inventors: Jeff Zablocki, Matthew Abelman, Michael Organ
-
Publication number: 20080207610Abstract: Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.Type: ApplicationFiled: January 24, 2008Publication date: August 28, 2008Inventors: Jeff Zablocki, Matthew Abelman, Michael Organ, Yaroslav Bilokin, Robert Jiang, Elfatih Elzein, Tetsuya Kobayashi, Rao Kalla, Thao Perry, Xiaofen Li, Ivan Diamond, Lina Yao, Peidong Fan, Maria Pia Arolfo, Zhan Jiang
-
Publication number: 20080032995Abstract: Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.Type: ApplicationFiled: July 27, 2007Publication date: February 7, 2008Inventors: Jeff Zablocki, Matthew Abelman, Michael Organ, Yaroslav Bilokin, Ivan Diamond, Maria Arolfo, Lina Yao, Peidong Fan, Elfatih Elzein, Rao Kalla, Thao Perry, Tetsuya Kobayshi, Xiaofen Lee, Robert Jiang
-
Patent number: 7300923Abstract: Disclosed are syntheses suitable for large scale manufacture of novel compounds that are partial and full A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.Type: GrantFiled: August 29, 2005Date of Patent: November 27, 2007Assignee: CV Therapeutics, Inc.Inventors: Jeff Zablocki, Elfatih Elzein, Michael Organ, Yaroslav Bilokin, Stanislas Mayer, Anthony Disanti, Scott Miller, Peter Kernast
-
Publication number: 20070212267Abstract: A reactor apparatus includes at least one reaction capillary having a lumen for receiving a reactant to undergo a reaction, and a magnetron for irradiating reactant contained in at least a portion of the capillary with microwaves. A method of micro-reacting a reactant includes providing a capillary, and irradiating the reactant in the capillary with microwaves to facilitate a chemical reaction in the capillary by which the reactant is converted into a desired product.Type: ApplicationFiled: February 28, 2007Publication date: September 13, 2007Applicant: Total Synthesis Ltd.Inventors: Michael Organ, Eamon Comer
-
Publication number: 20070073055Abstract: The present invention relates to catalysts of transition metal complexes of N-heterocyclic carbenes, their methods of preparation and their use in chemical synthesis. The synthesis, ease-of-use, and activity of the compounds of the present invention are substantial improvements over in situ catalyst generation. Further, the transition metal complexes of N-heterocyclic carbenes of the present invention may be used as precatalysts in metal-catalyzed cross-coupling reactions.Type: ApplicationFiled: August 23, 2006Publication date: March 29, 2007Applicant: Total Synthesis, Ltd.Inventors: Michael Organ, Christopher O'Brien, Assam (Eric) Kantchev
-
Publication number: 20060052330Abstract: Disclosed are syntheses suitable for large scale manufacture of novel compounds that are partial and full A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.Type: ApplicationFiled: August 29, 2005Publication date: March 9, 2006Inventors: Jeff Zablocki, Elfatih Elzein, Michael Organ, Yaroslav Bilokin, Stanislas Mayer, Anthony Disanti, Scott Miller, Peter Kernast
-
Patent number: 6105500Abstract: A method for preparing a substrate for a planographic printing plate is disclosed. A liquid that contains water; a soluble alkali metal silicate, preferably sodium silicate; and a dispersed particulate material is coated on a substrate, preferably aluminum or an aluminum alloy, to produce a hydrophilic layer on the substrate. A layer of image material may be coated over the substrate to produce a planographic printing plate. In one embodiment the liquid contains a mixture of two particulate materials: alumina and titanium dioxide.Type: GrantFiled: October 19, 1998Date of Patent: August 22, 2000Assignee: Kodak Polychrome Graphics LLCInventors: Harjit Singh Bhambra, Robert Michael Organ